Aleksandr Stiblo, GCT Director of Business Development, attended an online conference, one of the series of online events “120 minutes with Advantix Pharma”, dedicated to the Belarusian pharmaceutical industry.

While the global pandemic has affected pharmaceutical industry across the world, Belarus is finding new strategies of optimizing its work and coping with challenges. During the conference, changes in drug registration process, shifts in demand and pricing, new regulations in drug manufacturing and marketing were discussed.

If you are looking to conduct a clinical trial in EAEU region, including Russia, Kazakhstan and Belarus — contact us at for support.